Scribd Logo
Upload

Welcome to Scribd!

  • 19 views

    Heamocare Product

    Uploaded by

    Asad BNB
    Himont Pharmaceuticals' HEAMOCARE is an iron protein succinylate compound for treating iron deficiency anemia. It contains iron that is bound to a modified casein protein, allowing it to remain insoluble in the stomach but dissolve in the intestines for absorption. This protects the iron from gastric acid while still delivering it where it can be absorbed. HEAMOCARE has been shown to effectively correct iron deficiency anemia and restore hemoglobin levels through its controlled release of iron and high absorption rate. It also has a good safety and tolerability profile due to the low concentration of iron it delivers.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd

    Heamocare Product

    Uploaded by

    Asad BNB
    19 views15 pages
    Himont Pharmaceuticals' HEAMOCARE is an iron protein succinylate compound for treating iron deficiency anemia. It contains iron that is bound to a modified casein protein, allowing it to remain insoluble in the stomach but dissolve in the intestines for absorption. This protects the iron from gastric acid while still delivering it where it can be absorbed. HEAMOCARE has been shown to effectively correct iron deficiency anemia and restore hemoglobin levels through its controlled release of iron and high absorption rate. It also has a good safety and tolerability profile due to the low concentration of iron it delivers.

    Original Title

    HEAMOCARE PRODUCT

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Himont Pharmaceuticals' HEAMOCARE is an iron protein succinylate compound for treating iron deficiency anemia. It contains iron that is bound to a modified casein protein, allowing it to remain insoluble in the stomach but dissolve in the intestines for absorption. This protects the iron from gastric acid while still delivering it where it can be absorbed. HEAMOCARE has been shown to effectively correct iron deficiency anemia and restore hemoglobin levels through its controlled release of iron and high absorption rate. It also has a good safety and tolerability profile due to the low concentration of iron it delivers.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    19 views15 pages

    Heamocare Product

    Uploaded by

    Asad BNB
    Himont Pharmaceuticals' HEAMOCARE is an iron protein succinylate compound for treating iron deficiency anemia. It contains iron that is bound to a modified casein protein, allowing it to remain insoluble in the stomach but dissolve in the intestines for absorption. This protects the iron from gastric acid while still delivering it where it can be absorbed. HEAMOCARE has been shown to effectively correct iron deficiency anemia and restore hemoglobin levels through its controlled release of iron and high absorption rate. It also has a good safety and tolerability profile due to the low concentration of iron it delivers.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    of 15

    P

    Himont Pharmaceuticals

    HEAMOCARE Iron protein succinylate


    TREATMENT OF IDA
    OBJECTIVE
    • Correction of the disorder causing the anemia.
    • Correction of iron deficiency.
    • To restore the hemoglobin level to normal and
    • To restore the exhausted iron store.

    COMMONLY USED IRON SALTS


    • Salts Elemental iron content
    • Ferrous Sulphate 30%
    • Ferrous Gluconate 12%
    • Ferrous Fumarate 33%
    ROUTE OF ADMINISTRATION
    ORAL Parenteral route, either intramuscular
    or intravenous.
    IRON
    HEAMOCARE

    General Characteristics
    HEAMOCARE (Iron Proteinsuccinylate) is an
    iron compound for oral treatment of iron
    deficiency anemia.

    HEAMOCARE is an iron Protein complex in


    which iron is steadily bound to a succinylate
    casein with a solubility behavior strictly
    related to the pH modification.
    HEAMOCARE

    General Characteristics
    Due to this characteristic HEAMOCARE has
    the advantage, over common iron salts, of
    precipitating in the acidic gastric
    condition, keeping iron bound and of
    becoming soluble at natural or alkaline pH,
    thus allowing iron to be absorbed in the
    small intestine.
    HEAMOCARE

    Absorption
    • HEAMOCARE (IPS) is a proprietary form of ferric iron bound
    with a chemically modified protein (Casein) in a process
    called “Succinylation“ which dramatically stabilizes the
    complex.

    • This process is used to modify the solubility or hydrolysis in


    terms of pH which is insoluble at pH values below 5
    (stomach environment) while soluble at pH value above
    7(intestine environment).
    HEAMOCARE

    Pharmacological Profile

    IN HEAMOCARE the most important physical


    and chemical characteristics of the
    compounds are :
    1. Solubility at alkaline pH.
    Insolubility at acidic pH.
    HEAMOCARE

    Mode of Action
    In the stomach (pH below 4), the iron contained in HEAMOCARE remains almost “
    enclosed” within the protein envelope, and therefore protected against the acidic and
    peptic action of gastric juice.

    Therefore HEAMOCARE, as it does not free ferric ion, does not damage the lining, thus
    avoiding burning, pain etc. (side effects that are characteristic of all iron-based
    preparations

    Having reached the intestinal lumen (duodenum and jejunum) the compound dissolves
    as it is surrounded by an alkaline environment pH above 7);
    HEAMOCARE

    Toxicology
    According to the toxicological finding HEAMOCARE has
    shown a very good tolerability.

    Research demonstrates that HEAMOCARE IPS provides a


    steady controlled release of iron in a low concentration
    form, the possibility of toxic iron overload is impossible .
    HEAMOCARE

    Side effects
    Gastrointestinal disorder, such as
    Diarrhea,
    Nausea
    Epigastric pain,
    HEAMOCARE

    Interaction
    Iron derivatives may impair the absorption of
    tetracycline's
    DOSAGE

    Adults 15ml IN DAY


    (equivalent to 40mg elemental Iron)

    Children 1.5ml/kg/body weight in a day


    (equivalent to 4mg/kg/day)
    HEAMOCARE

    INDICATION
    1. IRON DIFICIENCY ANEMIA

    2. PREGNANCY

    3. GROWING AGE
    AN IDEAL IRON PREPARATION

    Better Absorption

    Established Efficacy Excellent Tolerability

    Acceptable Taste
    HEAMOCARE

    Features
    1. Research Molecule
    2. Latest formula for the treatment of IDA
    3. High GI tolerability due to unique formulation
    4. Rapid increase in Hb level due to high absorption rate.
    5. Unique mode of action
    6. High quality product
    7. High Patients compliance due to convenient dosage and
    economy.

    You might also like

    pFad - Phonifier reborn

    Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

    Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


    Alternative Proxies:

    Alternative Proxy

    pFad Proxy

    pFad v3 Proxy

    pFad v4 Proxy